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We show by immunohistochemical labeling that prominent cell types in the tumor microenvironment of
PyMT transgenic mice are tumor-associated macrophages (TAMs) and endothelial cells, and that both
populations are decreased in the presence of mitochondrial targeted catalase (mCAT). This observation
suggests that mitochondrial ROS can drive tumor invasiveness in conjunction with the presence of TAMs and
increased angiogenesis. Since primary PyMT tumor cells expressing mCAT undergo increased apoptosis,
mitochondrial antioxidants might be attractive anti-tumor agents.
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T
he oxidative stress theory of aging predicts that
attenuation of reactive oxygen species (ROS)
would delay aging and age-related diseases. We
have shown that mice with the human catalase gene
targeted to their mitochondria (mCAT) have decreased
cellular levels of mitochondrial ROS in association with
increased lifespan (1) and decreased incidence and
severity of age-related pathology (2). In particular, old
mice expressing mCAT had reduced non-hematopoeitic
tumor burden suggesting that age-associated malignant
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Fig. 1. F4/80 labeling for macrophages (brown stain) is decreased in primary breast tumors from PyMT transgenic mice expressing
mCAT compared to primary tumors from non-expressing PyMT mice.
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mitochondrial ROS. We showed the potential involve-
ment of the tumor microenvironment in a follow up
publication indicting that the tumor suppression by
mCAT occurred mainly in the invasive phase of tumor
progression and metastasis, and that cells in the tumor
microenvironment were likely key players (3). We report
in this short note that prominent cell types in the tumor
microenvironment of PyMT mice were tumor-associated
macrophages (TAMs) and endothelial cells, and that both
populations were decreased in the presence of mCAT.
We used F4/80 and CD34 to label TAMs and
endothelial cells, respectively. Formalin-fixed mammary
gland sections from samples previously described were
immunostainedaccordingtoourestablishedprocedure(3).
The number of F4/80 or CD34 labeled cells was deter-
mined by counting positive cells in a grid of eight
squares encompassing the entire plane of view at 20
magnification per slide. The labeling index was calculated
as the average per cent positive cells. As can be seen in
Fig. 1, F4/80 is reduced in primary tumors from PyMT
mCAT positive mice compared to primary tumors from
PyMT wild type mice, with respective labeling indices of
5893% and 1092, p50.02 (Fig. 2) suggesting a reduc-
tion in TAMs. A reduction in malignancy in association
with a decreased TAM population is consistent with
observations by Lin et al. (4), suggesting that TAMs play
a key role in regulating tumor growth in this model. The
authors went on to describe a reduction in angiogenesis
associated with the decrease in TAMs and reduced tumor
Fig. 2. The presence of mCAT in PyMT tumor cells is associated with a decreased labeling index (%) for F4/80 (macrophages) and
CD34 (vascular endothelial cells) and an increased labeling index for caspase 3 (apoptosis). N34 per cohort, *p50.05.
Fig. 3. CD34 labeling (brown stain) is decreased in primary breast tumors from PyMT transgenic mice expressing mCAT suggesting a
decrease in angiogenesis compared to primary tumors from non-expressing PyMT mice.
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mCAT positive PyMT mice, with decreased labeling for
CD34 positive endothelial cells compared to tumors from
wild type PyMT mice (Fig. 3). The difference in labeling
index between 1391 and 490.4, respectively, was sig-
nificant at p50.05 (Fig. 2). The data suggest that
mitochondrial ROS can drive tumor invasiveness via
TAMs and increased angiogenesis.
We previously showed that mCAT positive PyMT
tumor cells had a decreased proliferative capacity by ki-
67 labeling (3). In order to determine if apoptosis was a
contributing factor, we labeled primary tumor cells with
caspase 3 as described (5). Fig. 4 shows that tumors from
mCAT positive PyMT mice had increased labeling,
11.890.8%, compared to tumors from wild type PyMT
mice, 3.690.4%, p50.05, respectively, (Fig. 2) suggesting
that tumor cells expressing mCATwere adversely affected
by an increase in apoptosis. We speculate that mitochon-
drial ROS signaling drives stromal cell pro-tumor activity
and when this is attenuated by mCAT, stromal cells
undergo apoptosis resulting in decreased tumor growth.
The increased apoptosis would be consistent with the
decrease in angiogenesis. Therefore, catalase mimetics
that attenuate mitochondrial ROS (6) might be attractive
anti-tumor agents.
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Fig. 4. Caspase 3 labeling (brown cytoplasmic stain) is decreased in primary breast tumors from PyMT transgenic mice expressing
mCAT suggesting increased apoptosis, compared to primary tumors from non-expressing PyMT mice.
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